Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

被引：105

作者：

FitzSimons, D

François, G

Hall, A

McMahon, B

Meheus, A

Zanetti, A

Duval, B

Jilg, W

Böcher, WO

Lu, SN

Akarca, U

Lavanchy, D

Goldstein, S

Banatvala, J

Van Damme, P

机构：

[1] Univ Antwerp, WHO,Dept Epidemiol & Social Med, Collaborating Ctr Prevent & Control Viral Hepatit, Viral Hepatitis Prevent Board, B-2610 Antwerp, Belgium

[2] WHO, CH-1211 Geneva, Switzerland

[3] Univ London London Sch Hyg & Trop Med, Unit Infect Dis Epidemiol, London WC1E 7HT, England

[4] Ctr Dis Control & Prevent, Viral Hepatitis Program, Alaska Native Med Ctr, Anchorage, AK 99508 USA

[5] Ctr Dis Control & Prevent, Viral Hepatitis Program, Arctic Invest Program, Anchorage, AK 99508 USA

[6] Univ Milan, Inst Virol, I-20133 Milan, Italy

[7] Inst Natl Sante Publ Quebec, Grp Sci Immunisat, Beauport, PQ G1E 7G9, Canada

[8] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany

[9] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, D-55131 Mainz, Germany

[10] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Gastroenterol Hepatol, Kaohsiung 833, Taiwan

[11] Ege Univ, Fac Med, Dept Gastroenterol, Izmir, Turkey

[12] WHO, Dept Commun Dis Surveillance & Response, Global Alert & Response, CH-1211 Geneva, Switzerland

[13] Ctr Dis Control & Prevent, Div Viral Hepapitis, Atlanta, GA 30333 USA

[14] Guys Kings & St Thomas Sch Med & Dent, Div Infect, London, England

来源：

VACCINE | 2005年 / 23卷 / 32期

关键词：

hepatitis B; vaccine; long-term efficacy; booster policy; HBV mutants; vaccination programmes;

D O I：

10.1016/j.vaccine.2005.03.017

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska). (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：4158 / 4166

页数：9

共 72 条

[1]

Al-Faleh FZ, 1999, J INFECTION, V38, P167, DOI 10.1016/S0163-4453(99)90245-1

[2] HEPATITIS B-INFECTION IN SAUDI-ARABIA [J].

ALFALEH, FZ .

ANNALS OF SAUDI MEDICINE, 1988, 8 (06) :474-480

[3] INTEGRATION OF HEPATITIS-B VACCINE INTO THE EXPANDED PROGRAM ON IMMUNIZATION - THE SAUDI-ARABIAN EXPERIENCE [J].

ALFALEH, FZ ;

AYOOLA, EA ;

ALJEFFRY, M ;

ARIF, M ;

ALRASHED, RS ;

RAMIA, S .

ANNALS OF SAUDI MEDICINE, 1993, 13 (03) :231-236

[4] SEROEPIDEMIOLOGY OF HEPATITIS-B VIRUS-INFECTION IN SAUDI-ARABIAN CHILDREN - A BASE-LINE SURVEY FOR MASS VACCINATION AGAINST HEPATITIS-B [J].

ALFALEH, FZ ;

AYOOLA, EA ;

ARIF, M ;

RAMIA, S ;

ALRASHED, R ;

ALJEFFRY, M ;

ALMOFARREH, M ;

ALKARAWI, M ;

ALSHABRAWY, M .

JOURNAL OF INFECTION, 1992, 24 (02) :197-206

[5] COST-EFFECTIVENESS ANALYSIS OF HEPATITIS-B VACCINATION STRATEGIES IN CATALONIA, SPAIN [J].

ANTONANZAS, F ;

GARUZ, R ;

ROVIRA, J ;

ANTON, F ;

TRINXET, C ;

NAVAS, E ;

SALLERAS, L .

PHARMACOECONOMICS, 1995, 7 (05) :428-443

[6]

Ayoola AE, 2003, SAUDI MED J, V24, P991

[7]

Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6

[8] Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory [J].

Banatvala, J ;

Van Damme, P ;

Oehen, S .

VACCINE, 2000, 19 (7-8) :877-885

[9] 10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia) [J].

Berlioz-Arthaud, A ;

Perolat, P ;

Buisson, Y .

VACCINE, 2003, 21 (21-22) :2737-2742

[10] Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination:: Stimulation of the in vitro antibody response by interferon gamma [J].

Böcher, WO ;

Herzog-Hauff, S ;

Schlaak, J ;

zum Büschenfelde, KHM ;

Löhr, HF .

HEPATOLOGY, 1999, 29 (01) :238-244

← 1 2 3 4 5 6 7 8 →